C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 120 filers reported holding C4 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $428,236 | +225.6% | 75,794 | +7.2% | 0.08% | +192.9% |
| Q3 2023 | $131,508 | -18.5% | 70,703 | +20.6% | 0.03% | -12.5% |
| Q2 2023 | $161,279 | -3.6% | 58,647 | +10.1% | 0.03% | -33.3% |
| Q1 2023 | $167,293 | +13.7% | 53,278 | +113.7% | 0.05% | -66.4% |
| Q4 2022 | $147,105 | -34.0% | 24,933 | -2.1% | 0.14% | -30.2% |
| Q3 2022 | $223,000 | +21.9% | 25,470 | +4.8% | 0.20% | +47.5% |
| Q2 2022 | $183,000 | -65.5% | 24,314 | +11.2% | 0.14% | -44.4% |
| Q1 2022 | $531,000 | -40.7% | 21,868 | -21.3% | 0.25% | -23.3% |
| Q4 2021 | $895,000 | – | 27,791 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |